Evidence map›Paper›PMID 36109523›Full record

ArticleCell death & disease2022

Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis.

Chao Lu, Pengyun Qiao, Ruihai Fu, Yadi Wang, Jiayi Lu, Xi Ling, Lu Liu, Yujun Sun, Chune Ren, Zhenhai Yu

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chao LuDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China. vincentslu@163.com.
Pengyun QiaoDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China.
Ruihai FuDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China.
Yadi WangDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China.
Jiayi LuDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China.
Xi LingDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China.
Lu LiuDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China.
Yujun SunDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China.
Chune RenDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China. chuneren96@163.com.
Zhenhai YuDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, P. R. China. tomsyu@163.com.ORCID http://orcid.org/0000-0001-8928-6890
Weifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometriosis (EM) is one of the vanquished wonted causes of chronic pelvic sting in women and is closely associated with infertility. The long-term, complex, systemic, and post-treatment recurrence of EM wreaks havoc on women's quality of life. Extensive metabolic reprogramming (aerobic glycolysis, glucose overweening intake, and high lactate production) and cancer-like changes have been found in EM, which bears striking similarities to tumorigenesis. The key glycolysis regulator PFKFB4 is overexpressed in EM. However, the mechanism of PFKFB4 in EM remains unknown. We found that PFKFB4 was upregulated and was closely related to the progression of EM. We identified focus PIM2 as a new pioneering adjoin protein of PFKFB4. Vigorous biochemical methods were used to confirm that PIM2 phosphorylated site Thr140 of PFKFB4. PIM2 also could enhance PFKFB4 protein expression through the ubiquitin-proteasome pathway. Moreover, PIM2 expression was really corresponding prevalent with PFKFB4 in endometriosis in vivo. Importantly, phosphorylation of PFKFB4 on Thr140 by PIM2 promoted EM glycolysis and cell growth. Our study demonstrates that PIM2 mediates PFKFB4 Thr140 phosphorylation thus regulating glycolysis and EM progression. We illustrated a new mechanism that PIM2 simulated a central upstream partnership in the regulation of PFKFB4, and reveal a novel means of PIM2-PFKFB4 setting EM growth. Our research provided new theoretical support for further clarifying the reprogramming of EM glucose metabolism, and provided new clues for exploring non-contraceptive treatments for EM.

Indexed as

EndometriosisPhosphofructokinase-2AnaerobiosisCell ProliferationFemaleGlucoseGlycolysisHumansLactatesPhosphoric Monoester HydrolasesPhosphorylationProteasome Endopeptidase ComplexProtein Serine-Threonine KinasesProto-Oncogene ProteinsQuality of LifeUbiquitinsGlucoseLactatesPFKFB4 protein, humanPhosphofructokinase-2Phosphoric Monoester HydrolasesPIM2 protein, humanProteasome Endopeptidase ComplexProtein Serine-Threonine KinasesProto-Oncogene ProteinsUbiquitins

Identifiers

PMID36109523
PMCPMC9477845
OpenAlexW4295949612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.